AOL

Ozempic, Wegovy are getting generics as low as $15 around the world — what it means for Americans

The weight-loss world is on the brink of a major shake-up. Pharmaceutical companies in India will get the green light this weekend to start selling generic versions of Ozempic and Wegovy, with several ...
Yahoo Finance

India Opened the Floodgates on Weight-Loss Generics

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...
Indiatimes

Alarm over misuse of weight loss drugs as generics set to enter market

HYDERABAD: A surge in the unsupervised use of popular diabetes and weight-loss drugs in Hyderabad has raised alarm among doctors, who warn that social media trends and peer influence are pushing many ...
CNBC

India's weight-loss drug boom: Novo Nordisk talks about GLP-1 generics after patent expiry

Monday - Friday, 11:00 - 12:00 SIN/HK | 0500 - 06:00 CET In this video The patent on semaglutide, found in Novo Nordisk's Ozempic and Wegovy weight-loss drugs, expired in India on March 20. Vikrant ...
Mint

India’s weight-loss drug rush kicks off with generics 50-90% cheaper

AI Quick Read MUMBAI: A day after semaglutide lost patent protection in India, top drugmakers including Dr Reddy’s, Sun Pharma, and Zydus Lifesciences launched generic versions priced 50-90% below the ...
The New York Times

Ozempic Is About to Go Generic for Billions of People

In India, China and several other nations, Novo Nordisk is on the verge of losing patent protection for its blockbuster weight loss drug, opening the door for cheaper competing versions. By Rebecca ...
The Financial Express

Weight-loss drug prices down 70-90% as generics hit the shelves

In a shot in the arm for India’s high-growth weight-loss medicines market, generic versions of Danish drugmaker Novo Nordisk’s blockbuster drug semaglutide will hit the shelves on Saturday, with price ...
Business Line

Novo Nordisk’s semaglutide patent expiry on Friday — lower-cost generics poised for launch on Saturday

The high-profile obesity and diabetes products Wegovy and Ozempic, from Danish healthcare company Novo Nordisk, will see a significant global development on Friday — as a patent on its active ...
FiercePharma

With Novo's semaglutide going off patent, Indian drugmakers set to launch their cheaper generics

With patents expiring today in India for Novo Nordisk’s popular diabetes and obesity drugs Ozempic and Wegovy, more than 40 generic drug makers are expected to begin launching their cheaper versions ...
InfoWorld

Tap into the AI APIs of Google Chrome and Microsoft Edge

The Chrome and Edge browsers have built-in APIs for language detection, translation, summarization, and more, using locally ...
Forbes

Indian Pharma Billionaires Pile Into Generic Weight-Loss Drugs, Sparking Regulatory Scrutiny

This voice experience is generated by AI. Learn more. This voice experience is generated by AI. Learn more. Ozempic and Wegovy are injectable prescription weight-loss medicines made by Danish ...
The Financial Express

Indian pharma giants launch low-cost generic semaglutide injections

Indian pharma majors Sun Pharma, Dr Reddy’s, Glenmark, and Zydus Lifesciences on Saturday announced the launch of their generic versions of semaglutide injections, used for diabetes and weight ...